TCL Archive Duke University Settles 11 Medical Malpractice Cases Related to Potti’s trials December 9, 2011
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive In Brief: NCAB To Hear NCOG Appeal; FDA Renege On New Toxicology Protocol, Holds Up INDs April 24, 1981
TCL Archive In Brief: Fischinger Hints of “New Player” At FCRF; Gigliotti Named Cancer Control Science Director December 12, 1986
TCL Archive In Brief: Cancer Research Institute to Support AIDS Grants, With Maximum $70,000 Each; Deadline Is Oct. 1 July 15, 1983
